Innovaderma (LON:IDP)‘s stock had its “corporate” rating reaffirmed by investment analysts at FinnCap in a report issued on Thursday.
Shares of LON:IDP opened at GBX 73.50 ($0.96) on Thursday. Innovaderma has a 1 year low of GBX 117 ($1.53) and a 1 year high of GBX 410.50 ($5.36).
In other Innovaderma news, insider Joe Bayer bought 3,100 shares of the firm’s stock in a transaction dated Friday, November 16th. The shares were purchased at an average price of GBX 85 ($1.11) per share, for a total transaction of £2,635 ($3,443.09).
Innovaderma Company Profile
InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in Europe, the United States, Australasia, Asia, and Africa. It offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee name; and tailored solutions under the Leimo name for hair loss comprising shampoos, conditioners, and laser technology treatments developed to combat male and female hair loss, alopecia, thinning hair.
Further Reading: What is the NASDAQ Stock Market?
Receive News & Ratings for Innovaderma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovaderma and related companies with MarketBeat.com's FREE daily email newsletter.